Self-assigned ethnicity (should not be confused with nationality).Īn advanced calculator is also available at which combines QRISK® with QDScore® (which calculates risk of diabetes) and also enables you to work out how the risk would change with various interventions such as losing weight, better blood pressure control, use of statins and stopping smoking.Īll charts are based on groups of people with untreated levels of blood pressure, total cholesterol and HDL cholesterol.Systolic blood pressure (use current not pre-treatment value).Severe mental illness, including schizophrenia, bipolar disorder or moderate/severe depression.Postcode (postcode-related Townsend score) - a geographical measure of deprivation.Existing treatment with blood pressure agent (yes/no).Angina or heart attack in a first-degree relative Smoking status (non, ex, light, moderate, heavy).The current version of the calculator (QRISK®3) uses the following parameters (if known - missing values are calculated by a complex averaging procedure called multiple imputation) : Adults aged 85 years and over and those with existing CVD, type 1 diabetes, CKD or familial hypercholesterolaemia should be considered to be at an increased risk of CVD events without using QRISK®3. QRISK®3 is the recommended formal risk assessment tool to assess CVD risk for the primary prevention of CVD in people up to and including the age of 84 years. They were followed for 10 years, looking for the first development of CVD as an endpoint. This calculator was derived from data of a cohort of 1.28 million anonymised UK primary care patients without evidence of diabetes mellitus or CVD. People with moderate-to-high risk are more likely to be compliant with lifestyle changes and preventative medication if given information about their individual cardiovascular risk. People with a total CVD risk of over 10% over 10 years should be offered lipid-lowering treatment with a statin. Once all risk factors have been identified, cardiovascular risk charts or calculator should be used to estimate the total risk of developing CVD over the following 10 years.
FRAMINGHAM RISK SCORE GUIDELINES FULL
Decisions on treatment should be made after full explanation, and due note taken of the patient's needs and preferences. A patient-centred approach is essential and the risk assessment should be documented in the record. The tools are an aid to making clinical decisions about how intensively to intervene on lifestyle and whether to use antihypertensive and lipid-lowering medication. A systematic strategy, rather than a primarily opportunistic approach, should be adopted.